In November 2003, the American Cancer Society stated that breast cancer is the leading cause of death in women between the ages of 40 and 44. In the United States, there are about 200,000 new cases of breast cancer and more than 40,000 deaths; make the U.S. one of the countries with the highest death rate from breast cancer. Perhaps the most alarming statistic is 1: 8 women will eventually develop breast cancer during her life.
Generally accepted risk factors for developing breast cancer can be divided into two categories: that a woman can be controlled and that he can not. Women who choose pharmaceutical hormone replacement therapy (HRT) and oral contraceptives may increase the risk of breast cancer. In addition, women who take one or more alcoholic drinks a day or live a lifestyle face an increased risk for breast cancer. Factors outside the direct control but still can cause an increased risk include: onset of menstruation before age 12 or onset of menopause after age 50 and inheritance of breast cancer genes, BRCA 1 and BRCA 2. Inherited breast cancer genes, BRCA 1 and BRCA 2, which is known to be associated with both breast and ovarian cancer, but only account for 50-10% of all breast cancers. In 70% of all cases, the cause of breast cancer are still unknown.
Conventional screening methods all check structures. For example, mammography uses X-ray to examine breast tissue. Each structure has grown large enough to be seen by X-rays can be detected by mammography. However, mammography can have a high level of false positives. In fact, only 1 of 6 biopsies found to be positive for cancer when found by mammography or clinical breast examination. This leads to increased psychological stress, physical trauma and financial concerns.
Other risks include the display of mammography radiation, although this has been debated by doctors for years. Newly published in Radiation Research, 2004 authors show that the risks associated with mammography screening may FIVE times higher than previously assumed and the risk-benefit relationship should be reviewed mammography.
There is a technology that can detect breast issue YEARS before a tumor can be seen on X-ray or palpable during the test. The technology has been approved by the FDA as a screening tool ajuvan since 1982 and offers NO RADIATION, AND NO Compression Pain. For women who refuse to have a mammogram or those who want clinical correlation for the problem, digital IR thermal imaging may be of interest.
Thermal cameras detect heat emitted from the body and display it as an image on a computer monitor. Photographs that are unique to the person and remain stable over time. This is because of these characteristics that thermal images are valuable screening tools and effective.
Breast termografi suffered extensive research since the 1950s. There are more than 800 peer-reviewed studies on breast Thermography with more than 300,000 women included in large clinical trials. A normal termogram is 10 times more significant as an indicator of future risk for breast cancer than first order family history of disease. A normal termogram continually brings risk 22 times higher in affected breast cancer in the future.
Medical doctors who interpret the breast scans board certified and the last two years of training to qualify as a thermologist. Thermography is not limited by breast density and is ideal for women who have undergone cosmetic surgery or reconstructive. Recommended that since cancer typically has a life span of 15 years from onset to death, that she began playing at the age of 25 thermographic.
Thermographic screening is not covered by most insurance companies but surprisingly affordable for most people.
Generally accepted risk factors for developing breast cancer can be divided into two categories: that a woman can be controlled and that he can not. Women who choose pharmaceutical hormone replacement therapy (HRT) and oral contraceptives may increase the risk of breast cancer. In addition, women who take one or more alcoholic drinks a day or live a lifestyle face an increased risk for breast cancer. Factors outside the direct control but still can cause an increased risk include: onset of menstruation before age 12 or onset of menopause after age 50 and inheritance of breast cancer genes, BRCA 1 and BRCA 2. Inherited breast cancer genes, BRCA 1 and BRCA 2, which is known to be associated with both breast and ovarian cancer, but only account for 50-10% of all breast cancers. In 70% of all cases, the cause of breast cancer are still unknown.
Conventional screening methods all check structures. For example, mammography uses X-ray to examine breast tissue. Each structure has grown large enough to be seen by X-rays can be detected by mammography. However, mammography can have a high level of false positives. In fact, only 1 of 6 biopsies found to be positive for cancer when found by mammography or clinical breast examination. This leads to increased psychological stress, physical trauma and financial concerns.
Other risks include the display of mammography radiation, although this has been debated by doctors for years. Newly published in Radiation Research, 2004 authors show that the risks associated with mammography screening may FIVE times higher than previously assumed and the risk-benefit relationship should be reviewed mammography.
There is a technology that can detect breast issue YEARS before a tumor can be seen on X-ray or palpable during the test. The technology has been approved by the FDA as a screening tool ajuvan since 1982 and offers NO RADIATION, AND NO Compression Pain. For women who refuse to have a mammogram or those who want clinical correlation for the problem, digital IR thermal imaging may be of interest.
Thermal cameras detect heat emitted from the body and display it as an image on a computer monitor. Photographs that are unique to the person and remain stable over time. This is because of these characteristics that thermal images are valuable screening tools and effective.
Breast termografi suffered extensive research since the 1950s. There are more than 800 peer-reviewed studies on breast Thermography with more than 300,000 women included in large clinical trials. A normal termogram is 10 times more significant as an indicator of future risk for breast cancer than first order family history of disease. A normal termogram continually brings risk 22 times higher in affected breast cancer in the future.
Medical doctors who interpret the breast scans board certified and the last two years of training to qualify as a thermologist. Thermography is not limited by breast density and is ideal for women who have undergone cosmetic surgery or reconstructive. Recommended that since cancer typically has a life span of 15 years from onset to death, that she began playing at the age of 25 thermographic.
Thermographic screening is not covered by most insurance companies but surprisingly affordable for most people.
